Masuck T M, Taylor A R, Lough J
Department of Anatomy and Cellular Biology, Medical College of Wisconsin, Milwaukee 53226.
J Cell Physiol. 1990 Jul;144(1):12-7. doi: 10.1002/jcp.1041440103.
This laboratory has recently reported the occurrence of DNA nicking at the onset of terminal skeletal myogenesis by using the technique of in situ nick translation (Dawson and Lough: Dev. Biol., 127:362-367, 1988). Because 1-beta-D-arabinofuranosylcytosine (araC), a cytocidal agent that is routinely used to removed dividing fibroblasts from myogenic cultures, inhibits DNA repair, it was of interest to determine whether araC treatment resulted in an accumulation of the endogenously created nicks. Thus, we have assessed the accumulation of DNA nicks in myotube cells during a 20 hour araC treatment period at the onset of terminal myogenesis (44-64 hours in vitro) by using three techniques: alkaline sucrose gradient density centrifugation, kinetic in situ nick translation, and cellular in situ nick translation. Although alkaline sucrose gradient centrifugation revealed no detectable nicking after 20 hours, kinetic in situ nick translation analysis revealed subtle but significant increases in DNA nicks caused by araC within 7 hours of drug application, and a 1.5-fold increase in DNA repair sites after 20 hours of drug treatment. That these observations reflected nicking specifically in myotube nuclei was determined by immunocytochemical localization of nicked sites after repair with a biotinylated nucleotide analog (biotin-11-dUTP). The effects of araC were only incompletely reversible, whether or not the drug was removed from the cultures, within 2 days of the treatment period.(ABSTRACT TRUNCATED AT 250 WORDS)
本实验室最近通过原位缺口平移技术报道了在终末骨骼肌生成开始时DNA切口的出现(道森和洛夫:《发育生物学》,127:362 - 367,1988)。因为1-β-D-阿拉伯呋喃糖基胞嘧啶(araC),一种常用于从成肌培养物中去除增殖成纤维细胞的细胞杀伤剂,会抑制DNA修复,所以确定araC处理是否导致内源性产生的切口积累很有意义。因此,我们通过三种技术评估了在终末肌生成开始时(体外44 - 64小时)20小时araC处理期间肌管细胞中DNA切口的积累情况:碱性蔗糖梯度密度离心、动力学原位缺口平移和细胞原位缺口平移。尽管碱性蔗糖梯度离心显示20小时后未检测到切口,但动力学原位缺口平移分析显示,在药物应用7小时内araC导致DNA切口有细微但显著的增加,药物处理20小时后DNA修复位点增加了1.5倍。通过用生物素化核苷酸类似物(生物素-11-dUTP)修复后对切口位点进行免疫细胞化学定位,确定这些观察结果反映的是肌管细胞核中的特异性切口。无论在处理期2天内是否从培养物中去除药物,araC的作用只是部分可逆的。(摘要截短至250字)